New Page 1
Bangalore is top biotech city
Biotech companies from the bioclusters in West and South generated
revenues in excess of $1 billion in 2007-08. Maharashtra emerged as the leading
state with $900 million in revenues, while Bangalore was the top biotech city
contributing $550 million in sales during 2007-08. The biotech players in India
are well spread across the country. And for the past few years, it has been
observed that no single cluster has a monopoly on the revenues generated by
companies headquartered in their respective regions. This trend was observed in
The biotech companies in the Western Cluster,
comprising the states of Maharashtra, Gujarat and Goa, generated Rs
4,452.37 crore in revenues.
The West biocluster led the market in terms of
revenues generated by the companies in its region. Out of the total
revenues of Rs 10,274 crore generated by the biotech companies in
India in 2007-08, the West's share was 43.3 percent. It was
closely followed by South at 42.2 percent.
The Southern biocluster covering Andhra Pradesh,
Karnataka, and Tamil Nadu was close behind West with biotech
revenues of Rs 4,368.63 crore. Nine of the Top 20 biotech companies
have their base in the South.
The Northern cluster accounted for 14 percent
share of the total biotech revenues of Rs 10,274 crore generated in
The west region's contribution was led by Serum
Institute of India, the No. 1 biotech company in the country, which
accounted for over 22 percent share of the total revenues of Rs
4,452.37 crore clocked by the companies in the west. India's
largest biotech group, Biocon accounted for over 25 percent share of
the total contribution of Rs 4,369 crore from the Southern
Among the states, Maharashtra topped the
contribution with 35 percent share generating Rs 3615 crore.
Karnataka was second with 21.6 percent share (Rs 2220 crore) and
Andhra Pradesh followed it with Rs 1,830 crore in value terms and
with a 17.82 percent share.
Almost three-fourths of the total biotech
business in the country was contributed by the companies in these
Bangalore was the No.1 biotech city generating
revenues of Rs 2,220 crore and 21.6 percent share.
Mumbai was second with revenues of Rs 1,975 crore
and Hyderabad was next with Rs 1,830 crore in biotech revenues.
The NCR region accounted for 14 percent share (Rs
1,453 crore) and was followed by Pune with 12 percent share and
revenues of Rs 1,254 crore.
Panacea Biotech was the largest player in the North
contributing more than 46 percent of the total biotech revenues from
the NCR cluster.
Serum was the largest contributor to the West with
27.3 percent share While Biocon led the Karnataka regions fortunes,
Nuziveedu Seeds, the country's largest bioagri company, with
revenues of Rs 303 crore, was the largest contributor to the business
from Andhra Pradesh with close to 17 percent share.
The Top 3 companies in West accounted for 29
percent share of the region.
The Top 3 companies in North generated 67 percent
of the total revenues of the region.
The Top 3 companies in South contributed 35 percent
of the revenues of the region.
The Top 3 companies in Maharashtra accounted for 35
percent share in the region.
The Top 3 companies in Gujarat generated 30 percent
of the total revenues in Gujarat.
The Top 3 companies in Karnataka contributed 63
percent of the total revenues.
- The Top 3 companies' share in Andhra Pradesh was 35.46 percent.